Literature DB >> 27603214

Multiple Autoantibodies and Neuromyelitis Optica Spectrum Disorders.

Chen Chen1, Sun Xiaobo, Wang Yuge, Shu Yaqing, Fang Ling, Peng Lisheng, Lu Zhengqi, Qiu Wei.   

Abstract

OBJECTIVE: To investigate the relationship between neuromyelitis optica spectrum disorder (NMOSD) and autoantibodies.
METHODS: Blood samples of 108 NMOSD patients and 38 controls were collected from January 2012 to August 2014. Immunological parameters, including anti-aquaporin 4, antinuclear, anti-ribonucleoprotein, anti-SM, anti-SSA/Ro, anti-SSB/La and anti-ribosomal P-protein autoantibodies were examined.
RESULTS: The NMOSD group exhibited a significantly higher percentage of anti-aquaporin 4 antibodies compared with the control group (76.9 vs. 0.0%, p = 0). The positive rates for antinuclear and anti-SSA antibodies in the NMOSD group were also higher than in the control group (35.2 vs. 11.8%, p = 0.001; 13.0 vs. 0.0%, p = 0.044). In total, 36.1% of the patients in the NMOSD group were seropositive for autoantibodies but only 8.3% were diagnosed with definite systemic autoimmune disorders.
CONCLUSIONS: NMOSD is closely associated with elevated autoantibodies, particularly antinuclear and anti-SSA/Ro antibodies. NMOSD rarely coexists with organ-specific autoimmune diseases.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27603214     DOI: 10.1159/000448286

Source DB:  PubMed          Journal:  Neuroimmunomodulation        ISSN: 1021-7401            Impact factor:   2.492


  3 in total

1.  Serum antinuclear antibodies associate with worse prognosis in AQP4-positive neuromyelitis optica spectrum disorder.

Authors:  Rong Fan; Yuefeng Zhang; Yunqi Xu; Jiayi Tong; Zhigang Chen; Meifeng Gu; Wenkui Fan; Yong Chen; Fuhua Peng; Ying Jiang
Journal:  Brain Behav       Date:  2020-12-14       Impact factor: 2.708

2.  Elevated Concentrations of Soluble Fas and FasL in Multiple Sclerosis Patients with Antinuclear Antibodies.

Authors:  Josip Sremec; Sanja Tomasović; Nada Tomić Sremec; Alan Šućur; Jelena Košćak Lukač; Koraljka Bačić Baronica; Danka Grčević; Nataša Kovačić
Journal:  J Clin Med       Date:  2020-11-26       Impact factor: 4.241

3.  Comparative study of AQP4-NMOSD, MOGAD and seronegative NMOSD: a single-center Belgian cohort.

Authors:  Solène Dauby; Dominique Dive; Laurence Lutteri; Cécile Andris; Isabelle Hansen; Pierre Maquet; Emilie Lommers
Journal:  Acta Neurol Belg       Date:  2021-06-07       Impact factor: 2.396

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.